NCT02143466 2026-01-30
AZD9291 in Combination With Ascending Doses of Novel Therapeutics
AstraZeneca
Phase 1 Active not recruiting
Clinical Trials
4 trialsNCT04032847 2025-03-10
ATL001 in Patients With Advanced Unresectable or Metastatic NSCLC
Achilles Therapeutics UK Limited
Phase 1/2 Terminated
NCT06107374 2024-10-24
Imaging Advanced NSCLC Patients Undergoing PD-1/PD-L1 Directed Therapy Using [18F]-FARAG
CellSight Technologies, Inc.
Phase 2 Recruiting
NCT03452150 2023-04-25
D-0316 First Time in Patients Ascending Dose Study
InventisBio Co., Ltd
Phase 1 Completed